Effects of ultrasound-guided thoracic paravertebral nerve block combined with hydromorphone on postoperative analgesia and inflammatory response after thoracoscopy surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300074082

Enrollment

Unknown

Registered

2023-07-28

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

C group:The anesthetic induction drugs are Midazolam 0.03mg/kg and sufentanil 0.5 µ G/kg, propofol 2mg/kg, rocuronium 0.6mg/kg. After the Anesthetic takes full effect, the double lumen bronchial tube

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? ASA Level I-III; ? Age 20-80 years old; ? Weight 45-80 kg; ? Ethical and informed consent.

Exclusion criteria

Exclusion criteria: ? Preoperative opioid addiction; ? Mental and Nervous system disease; ? History of asthma; ? Severe cardiopulmonary dysfunction and liver and kidney dysfunction; ? Patients who refuse to cooperate with the trial; ? Skin lesions at the puncture site, history of severe vomiting or motion sickness, and communication difficulties.

Design outcomes

Primary

Measure	Time frame
VAS scores;BCS scores;	—

Secondary

Measure	Time frame
Number of compressions for self-control analgesia relief;CRP;IL-6;	—

Countries

China

Contacts

Public ContactOuyang Yinghui

Shifang people's Hospital

343329636@qq.com+86 189 8107 7236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026